Search results
Results from the WOW.Com Content Network
Rhizopus microsporus causes rice seedling blight and is a severe crop disease in Asia. [15] In addition, R. microsporus significantly affects sunflower yield in terms of both (oil) quality and quantity. The free fatty acid content of sunflower oil increases from 0.8% to 19.4%.
Antibiotics by class Generic name Brand names Common uses [4] Possible side effects [4] Mechanism of action Aminoglycosides; Amikacin: Amikin: Infections caused by Gram-negative bacteria, such as Escherichia coli and Klebsiella particularly Pseudomonas aeruginosa. Effective against aerobic bacteria (not obligate/facultative anaerobes) and ...
Rhizoxin is biosynthesised by Paraburkholderia rhizoxinica, a bacterial endosymbiont of the fungus Rhizopus microsporus. [3] It is one of a large group of rhizoxin-like compounds produced by the bacteria. [4] The bacterial endosymbiont can be grown independently in culture.
This is a list of common β-lactam antibiotics—both administered drugs and those not in clinical use—organized by structural class. Antibiotics are listed alphabetically within their class or subclass by their nonproprietary name. If an antibiotic is a combination drug, both ingredients will be listed.
Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04
Rhizopus microsporus ssp. oligosporus: fungus: soy oncom [6] Rhizopus microsporus ssp. oligosporus: fungus: soy tempeh [2] [5] [6] Rhodosporidium infirmominiatum: fungus: cheese [4] Rhodotorula glutinis: fungus: chocolate [1] Rhodotorula minuta: fungus: cheese (smear-ripened) [4] Rhodotorula rubra: fungus: chocolate [1] Saccharomyces bayanus ...
Rhizopus is a genus of common saprophytic fungi on plants and specialized parasites on animals. They are found in a wide variety of organic substances, including "mature fruits and vegetables", [ 2 ] jellies, syrups, leather, bread, peanuts, and tobacco.
Between 1975 and 1999 only 13 of 1,300 new drugs were antiparasitics, which raised concerns that insufficient incentives existed to drive development of new treatments for diseases that disproportionately target low-income countries.